Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
AVAI
)
0.2925
UNCHANGED
Streaming Delayed Price
Updated: 3:39 PM EST, Dec 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.2925
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.2925
Today's Range
0.2925 - 0.2925
52wk Range
0.2191 - 0.8400
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
THE FOUNDATION TRADE: 5 Assets Anchoring the Next Industrial Cycle
December 17, 2025
Issued on behalf of GoldHaven Resources Corp.
From
USA News Group
Via
GlobeNewswire
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
December 16, 2025
Issued on behalf of Avant Technologies Inc.
From
USA News Group
Via
GlobeNewswire
Performance
YTD
-39.7%
-39.7%
1 Month
-4.1%
-4.1%
3 Month
-12.8%
-12.8%
6 Month
-50.4%
-50.4%
1 Year
-50.2%
-50.2%
More News
Read More
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
December 15, 2025
From
USA News Group
Via
GlobeNewswire
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
December 09, 2025
From
Avant Technologies Inc.
Via
Business Wire
THE CRITICAL LIST: 5 Stocks Anchoring the New Economy
December 08, 2025
From
USA News Group
Via
GlobeNewswire
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
December 06, 2025
From
USA News Group
Via
GlobeNewswire
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care
November 19, 2025
From
USA News Group
Via
GlobeNewswire
Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
November 18, 2025
From
MarketNewsUpdates.com
Via
GlobeNewswire
Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
November 18, 2025
Via
FinancialNewsMedia
Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies
November 18, 2025
From
Avant Technologies, Inc.
Via
Business Wire
Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment
November 04, 2025
From
Avant Technologies Inc.
Via
Business Wire
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
September 18, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Avant Technologies and Austrianova Sign Joint Venture, Licensing Agreement to Advance Klotho-Based Therapies
September 18, 2025
Via
FinancialNewsMedia
Topics
Intellectual Property
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
August 12, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Avant Technologies’ Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference
July 22, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
July 22, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Ainnova Tech Reaches Major FDA Milestone in AI-Powered Diabetic Retinopathy Detection
July 17, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
July 15, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA
July 15, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Healthcare’s $110B AI Surge Is Picking Up Speed—and It’s Just the Beginning
July 08, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Doctors Are Being Outpaced by AI-Powered Algorithms — Here’s What It Means for Investors
July 07, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Fraud
New AI Rollouts Signal Shift From Hype to Healthcare Reality
June 24, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health
June 17, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
June 17, 2025
Via
FinancialNewsMedia
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
June 17, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Frequently Asked Questions
Is AVAI publicly traded?
Yes, AVAI is publicly traded.
What exchange does AVAI trade on?
AVAI trades on the OTC Traded
What is the ticker symbol for AVAI?
The ticker symbol for AVAI is AVAI on the OTC Traded
What is the current price of AVAI?
The current price of AVAI is 0.2925
When was AVAI last traded?
The last trade of AVAI was at 12/26/25 03:39 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.